{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O18158",
      "entity_text" : "O-GlcNAc",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Studies have demonstrated that the acute augmentation of O-GlcNAc levels improves the tolerance to stress stimuli, confers cardioprotective effects against ischemia-reperfusion (IR) injury, blunts the cardiomyocyte nuclear factor of activated T-cells (NFAT)-induced changes during hypertrophy and attenuates vascular inflammation.",
  "reading_complete" : "2020-08-03T12:48:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:46:34Z",
  "trigger" : "attenuates",
  "evidence" : [ "O-GlcNAc levels improves the tolerance to stress stimuli              , confers cardioprotective effects against ischemia-reperfusion (IR) injury              , blunts the cardiomyocyte nuclear factor of activated T-cells (NFAT)-induced changes during hypertrophy               and attenuates vascular inflammation" ],
  "pmc_id" : "4494595",
  "score" : 0
}